308.16
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ELV?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$313.64
Offen:
$315.62
24-Stunden-Volumen:
2.01M
Relative Volume:
0.87
Marktkapitalisierung:
$69.39B
Einnahmen:
$189.25B
Nettoeinkommen (Verlust:
$5.35B
KGV:
13.11
EPS:
23.5
Netto-Cashflow:
$5.34B
1W Leistung:
-3.29%
1M Leistung:
+4.82%
6M Leistung:
-24.74%
1J Leistung:
-43.13%
Elevance Health Inc Stock (ELV) Company Profile
Firmenname
Elevance Health Inc
Sektor
Branche
Telefon
(800) 331-1476
Adresse
220 VIRGINIA AVENUE, INDIANAPOLIS
Vergleichen Sie ELV mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ELV
Elevance Health Inc
|
308.16 | 70.62B | 189.25B | 5.35B | 5.34B | 23.50 |
![]()
UNH
Unitedhealth Group Inc
|
320.25 | 285.64B | 422.82B | 22.09B | 25.27B | 23.08 |
![]()
CVS
Cvs Health Corp
|
70.26 | 93.58B | 386.46B | 4.49B | 4.78B | 3.58 |
![]()
CI
Cigna Group
|
300.89 | 81.50B | 261.22B | 5.40B | 3.94B | 18.32 |
![]()
HUM
Humana Inc
|
310.38 | 37.03B | 123.11B | 1.58B | 2.44B | 13.03 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-07-21 | Herabstufung | Argus | Buy → Hold |
2025-07-18 | Herabstufung | Leerink Partners | Outperform → Market Perform |
2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2025-03-17 | Hochstufung | Argus | Hold → Buy |
2025-01-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
2024-10-18 | Herabstufung | Argus | Buy → Hold |
2024-07-18 | Herabstufung | BofA Securities | Buy → Neutral |
2024-06-24 | Eingeleitet | Morgan Stanley | Overweight |
2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
2024-03-06 | Eingeleitet | Barclays | Overweight |
2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
2023-04-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
2023-03-28 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
2022-09-09 | Hochstufung | BofA Securities | Neutral → Buy |
2022-08-22 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
Alle ansehen
Elevance Health Inc Aktie (ELV) Neueste Nachrichten
Elevance Health: Keep It Simple And Buy This Great Business At A Low Valuation - Seeking Alpha
Ex-Dividend Reminder: Elevance Health, Pathward Financial and UMB Financial - Nasdaq
Elevance Health files for 4-part notes offering size not disclosedSEC filing - MarketScreener
Form 424B3 Elevance Health, Inc. - StreetInsider
Elevance Health (NYSE:ELV) Has A Pretty Healthy Balance Sheet - Yahoo Finance
Can Elevance Health's Value-Based Care Strategy Fuel Long-Term Growth? - MSN
What’s the recovery path for long term holders of Elevance Health Inc.July 2025 Decliners & Consistent Return Strategy Ideas - Newser
How is Elevance Health Inc. managing supply chain issuesJuly 2025 Reactions & Smart Money Movement Tracker - خودرو بانک
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Will Elevance Health Inc. benefit from macro trendsBull Run & Low Drawdown Investment Ideas - Newser
Is Elevance Health Inc.’s ROIC above industry averageWeekly Investment Report & Weekly Momentum Picks - خودرو بانک
Real time scanner hits for Elevance Health Inc. explainedJuly 2025 Recap & Fast Gain Swing Alerts - Newser
Be Sure To Check Out Elevance Health, Inc. (NYSE:ELV) Before It Goes Ex-Dividend - simplywall.st
Elevance Health Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Why Elevance Health (ELV) Stock Is Trading Lower Today - TradingView
Elevance Health (ELV) Reaffirms 2025 Earnings and Expense Guidan - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elevance Health, Inc. (ELV) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Elevance Health exits Part D, some Medicare Advantage markets - Modern Healthcare
Elevance Health (ELV) Shares Decline on Weak Medicaid Margin Out - GuruFocus
Barclays Raises Price Target for Elevance Health (ELV) to $373 | - GuruFocus
Elevance falls on softer margin estimate, reaffirmed 2025 guidance - Seeking Alpha
Elevance Health Reaffirms 2025 Earnings Guidance - MSN
Why is Elevance Health Inc. stock going downQuarterly Earnings Report & Short-Term High Return Ideas - خودرو بانک
Insiders At Elevance Health Sold US$6.7m In Stock, Alluding To Potential Weakness - Yahoo Finance
Elevance Health reaffirms 2025 earnings and benefit expense guidance By Investing.com - Investing.com Canada
Elevance Health reaffirms 2025 earnings and benefit expense guidance - Investing.com
Elevance Health Inc to reaffirm 2025 earnings guidance at $24.10 per shareSEC filing - MarketScreener
Chart based analysis of Elevance Health Inc. trendsMarket Movement Recap & AI Forecasted Entry and Exit Points - Newser
Can trapped investors hope for a rebound in Elevance Health Inc.Weekly Profit Summary & Verified Entry Point Signals - Newser
Analyzing drawdowns of Elevance Health Inc. with statistical toolsJuly 2025 News Drivers & Weekly High Return Stock Forecasts - Newser
Elevance Health Inc. stock outlook for YEARMarket Trend Review & Safe Capital Preservation Plans - Newser
Is Elevance Health Stock Underperforming the S&P 500? - MSN
Is Elevance Health Stock Underperforming The S&P 500? - Barchart.com
Predicting Elevance Health Inc. trend using moving averagesPortfolio Value Summary & Consistent Profit Trading Strategies - Newser
Elevance Health Foundation Awards $6.5 Million to Strengthen Maternal and Infant Health Across the United States - Business Wire
What machine learning models say about Elevance Health Inc.Chart Signals & Comprehensive Market Scan Reports - Newser
Key resistance and support levels for Elevance Health Inc.Bond Market & Community Verified Watchlist Alerts - Newser
Is Elevance Health Inc. benefiting from interest rate changes2025 AllTime Highs & High Conviction Buy Zone Alerts - خودرو بانک
Elevance Health, Inc. (ELV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Cyberattack Hangover: Senators Question UnitedHealth's Loan Playbook - TradingView
Understanding Elevance Health Inc.’s price movement2025 Growth vs Value & Technical Pattern Recognition Alerts - Newser
Is now a turning point for Elevance Health Inc.July 2025 Technicals & Real-Time Stock Movement Alerts - Newser
Elevance Health Inc. Stock Flags Risk Zone in Volatility Index getLinesFromResByArray error: size == 0 - thegnnews.com
Elevance Health Inc. stock trend forecastQuarterly Market Summary & Daily Stock Trend Watchlist - Newser
Is Elevance Health Inc. in a consolidation phaseJuly 2025 Short Interest & AI Driven Price Predictions - خودرو بانک
Will Elevance Health Inc. outperform the market in YEARMarket Movement Recap & Capital Efficiency Focused Strategies - خودرو بانک
Will Elevance Health Inc. be affected by tariffsWeekly Volume Report & Risk Managed Investment Signals - khodrobank.com
Using AI based signals to follow Elevance Health Inc.2025 Support & Resistance & Reliable Breakout Forecasts - Newser
Can volume confirm reversal in Elevance Health Inc.Portfolio Value Summary & High Conviction Investment Ideas - Newser
Reversal indicators forming on Elevance Health Inc. stockGap Up & High Accuracy Investment Entry Signals - Newser
Published on: 2025-09-01 14:18:19 - Newser
Finanzdaten der Elevance Health Inc-Aktie (ELV)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):